NEW DELHI : Tata Medical and Diagnostics Ltd on Monday launched its covid-19 test under the brand ‘Check’. The paper based test is powered by the Feluda technology it developed along with Council of Scientific and Industrial Research’s constituent lab, Institute of Genomics and Integrative Biology (CSIR-IGIB).The TataMD Check test kits will be manufactured at the company’s facility near Chennai, which currently has a capacity of producing 1 million kits in a month, Tata Medical said in a statement.“Our collaboration with R&D institutions will continue to be a critical part of our strategy to introduce new diagnostic technologies like CRISPR, and develop R&D-led healthcare solutions for consumers for COVID and other infectious diseases,".